Design, synthesis and biological evaluation of novel pyrimidinedione derivatives as DPP-4 inhibitors

被引:30
|
作者
Li, Ning [1 ,2 ,3 ,4 ]
Wang, Li-Jun [1 ,2 ,4 ]
Jiang, Bo [1 ,2 ,4 ]
Guo, Shu-Ju [1 ,2 ,4 ]
Li, Xiang-Qian [1 ,2 ,4 ]
Chen, Xue-Chun [5 ]
Luo, Jiao [1 ,2 ,3 ,4 ]
Li, Chao [1 ,2 ,3 ,4 ]
Wang, Yi [5 ]
Shi, Da-Yong [1 ,2 ,3 ,4 ]
机构
[1] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao 266071, Peoples R China
[2] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Drugs & Bioprod, Qingdao 266235, Peoples R China
[3] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[4] Chinese Acad Sci, Ctr Ocean Mega Sci, Qingdao 266071, Peoples R China
[5] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Zhejiang, Peoples R China
基金
美国国家科学基金会; 中国国家自然科学基金;
关键词
Pyrimidinedionederivatives; DPP-4; inhibitor; Molecular hybrid; SARs; Type; 2; diabetes; ALGA RHODOMELA-CONFERVOIDES; DIPEPTIDYL PEPTIDASE-4 INHIBITORS; PHOSPHATASE 1B INHIBITOR; C57BL/KSJ-DB/DB MICE; BROMOPHENOLS; DISCOVERY; HPN;
D O I
10.1016/j.bmcl.2018.05.022
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel pyrimidinedione derivatives were designed and evaluated for in vitro dipeptidyl peptidase-4 (DPP-4) inhibitory activity and in vivo anti-hyperglycemic efficacy. Among them, the representative compounds 11, 15 and 16 showed excellent inhibitory activity of DPP-4 with IC50 values of 64.47 nM, 188.7 nM and 65.36 nM, respectively. Further studies revealed that compound 11 was potent in vivo hypoglycemic effect. The structure-activity relationships of these pyrimidinedione derivatives had been discussed, which would be useful for developing novel DPP-4 inhibitors as treating type 2 diabetes.
引用
收藏
页码:2131 / 2135
页数:5
相关论文
共 50 条
  • [21] Discovery of novel heterocyclic derivatives containing oxadiazolone or pyrimidinone cores as DPP-4 inhibitors
    Feitosa, Sidney Gustavo Diniz
    Lins, Ilaria Martina Silva
    Maciel, Larissa Goncalves
    dos Anjos, Janaina Versiani
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2024, 61 (06) : 861 - 874
  • [22] Synthesis and biological evaluation of triazepane derivatives as DPP-IV inhibitors
    Park, Woul Seong
    Jun, Mi Ae
    Shin, Mi Sik
    Kwon, Sung Wook
    Kang, Seung Kyu
    Kim, Ki Young
    Rhee, Sang Dal
    Bae, Myung Ae
    Narsaiah, Banda
    Lee, Duck Hyung
    Cheon, Hyae Gyeong
    Ahn, Jin Hee
    Kim, Sung Soo
    JOURNAL OF FLUORINE CHEMISTRY, 2009, 130 (11) : 1001 - 1010
  • [23] Design, synthesis, and biological evaluation of novel aminopyrimidine derivatives as EGFR inhibitors
    Wang, Huabing
    Gui, Yule
    Cui, Shengkai
    Long, Xinyi
    Fan, Weizheng
    Tang, Chunlei
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2025, 122
  • [24] Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as potential PDE4 inhibitors
    Song, Gaopeng
    Zha, Dongsheng
    Hu, Dekun
    Li, Yasheng
    Jin, Hongwei
    Cui, Zining
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (20) : 4610 - 4614
  • [25] Design, synthesis, and biological evaluation of triazolopiperazine-based β-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors
    Kowalchick, Jennifer E.
    Leiting, Barbara
    Pryor, KellyAnn D.
    Marsilio, Frank
    Wu, Joseph K.
    He, Huaibing
    Lyons, Kathryn A.
    Eiermann, George J.
    Petrov, Aleksandr
    Scapin, Giovanna
    Patel, Reshma A.
    Thornberry, Nancy A.
    Weber, Ann E.
    Kim, Dooseop
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (21) : 5934 - 5939
  • [26] Discovery of new binding elements in DPP-4 inhibition and their applications in novel DPP-4 inhibitor design
    Liang, Gui-Bai
    Qian, Xiaoxia
    Biftu, Tesfaye
    Singh, Suresh
    Gao, Ying-Duo
    Scapin, Giovanna
    Patel, Sangita
    Leiting, Barbara
    Patel, Reshma
    Wuc, Joseph
    Zhang, Xiaoping
    Thornberry, Nancy A.
    Weber, Ann E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (13) : 3706 - 3710
  • [27] Novel Potent and Selective DPP-4 Inhibitors: Design, Synthesis and Molecular Docking Study of Dihydropyrimidine Phthalimide Hybrids
    Mourad, Ahmed A. E.
    Khodir, Ahmed E.
    Saber, Sameh
    Mourad, Mai A. E.
    PHARMACEUTICALS, 2021, 14 (02) : 1 - 24
  • [28] Modeling assisted rational design of novel, potent, and selective pyrrolopyrimidine DPP-4 inhibitors
    Gao, Ying-Duo
    Feng, Dennis
    Sheridan, Robert P.
    Scapin, Giovanna
    Patel, Sangita B.
    Wu, Joseph K.
    Zhang, Xiaoping
    Sinha-Roy, Ranabir
    Thornberry, Nancy A.
    Weber, Ann E.
    Biftu, Tesfaye
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (14) : 3877 - 3879
  • [29] Design, synthesis, and biological evaluation of thienopyrimidine derivatives as DPP IV inhibitors for the treatment of type 2 diabetes
    Wang, Jiang
    Liu, Hong
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [30] Design and synthesis of tetrahydropyridopyrimidine derivatives as dual GPR119 and DPP-4 modulators
    Fang, Yuanying
    Zhang, Shaokun
    Wu, Wenting
    Liu, Yanhua
    Yang, Juan
    Li, Yuyuan
    Li, Min
    Dong, Huanhuan
    Jin, Yi
    Liu, Ronghua
    Yang, Zunhua
    BIOORGANIC CHEMISTRY, 2020, 94